portunities for effective patient self-management; 
and 
‘‘(2) shall give priority to reaching high-risk or 
underserved populations. 
‘‘(d) COLLABORATION.—In carrying out this section, 
the Secretary shall consult and collaborate with stake- 
holders from the public, private, and nonprofit sectors 
with expertise relating to arthritis control, prevention, and 
treatment. 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
such sums as may be necessary for each of fiscal years 
2008 through 2012.’’. 
SEC. 4. EXPANSION AND COORDINATION OF ACTIVITIES OF 
THE NATIONAL INSTITUTES OF HEALTH WITH 
RESPECT TO RESEARCH ON ARTHRITIS. 
Title IV of the Public Health Service Act (42 U.S.C. 
281 et seq.) is amended by inserting after section 439 the 
following: 
‘‘SEC. 439A. ARTHRITIS AND RHEUMATIC DISEASES INTER-
AGENCY COORDINATING COMMITTEE. 
‘‘(a) IN GENERAL.— 
‘‘(1) ESTABLISHMENT.—The Secretary shall es-
tablish an Arthritis and Rheumatic Diseases Inter-
VerDate Aug 31 2005 
17:35 Mar 03, 2007
Jkt 059200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H1283.IH
H1283
pwalker on PROD1PC71 with BILLS
agency Coordinating Committee (referred to in this 
section as the ‘Coordinating Committee’). 
‘‘(2) DUTIES.—The coordinating committee es-
tablished under paragraph (1) shall— 
‘‘(A) provide for the improved coordination 
of the research activities of all the national re-
search institutes relating to arthritis and rheu-
matic diseases; and 
‘‘(B) provide for full and regular commu-
nication and exchange of information necessary 
to maintain adequate coordination across all 
Federal health programs and activities related 
to arthritis and rheumatic diseases. 
‘‘(b) ARTHRITIS AND RHEUMATIC DISEASES INTER-
AGENCY COORDINATING COMMITTEE.— 
‘‘(1) COMPOSITION.—The Coordinating Com-
mittee shall consist of members, appointed by the 
Secretary, of which— 
‘‘(A) 2⁄3 of such members shall represent 
governmental agencies, including— 
‘‘(i) the directors of each of the na-
tional research institutes and divisions in-
volved in research regarding arthritis and 
rheumatic diseases (or the directors’ re-
spective designees); and 
VerDate Aug 31 2005 
17:35 Mar 03, 2007
Jkt 059200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H1283.IH
H1283
pwalker on PROD1PC71 with BILLS
‘‘(ii) representatives of other Federal 
departments and agencies (as determined 
appropriate by the Secretary) whose pro-
grams involve health functions or respon-
sibilities relevant to arthritis and rheu-
matic diseases, including the Centers for 
Disease 
Control 
and 
Prevention, 
the 
Health Resources and Services Administra-
tion, and the Food and Drug Administra-
tion; and 
‘‘(B) 1⁄3 of such members shall be public 
members, including a broad cross section of 
persons affected by arthritis, researchers, clini-
cians, and representatives of voluntary health 
agencies, who— 
‘‘(i) shall serve for a term of 3 years; 
and 
‘‘(ii) may serve for an unlimited num-
ber of terms if reappointed. 
‘‘(2) CHAIRPERSON.— 
‘‘(A) APPOINTMENT.—The Chairperson of 
the Coordinating Committee (referred to in this 
subsection as the ‘Chairperson’) shall be ap-
pointed by and be directly responsible to the 
Secretary. 
VerDate Aug 31 2005 
17:35 Mar 03, 2007
Jkt 059200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H1283.IH
H1283
pwalker on PROD1PC71 with BILLS
‘‘(B) DUTIES.—The Chairperson shall— 
‘‘(i) serve as the principal advisor to 
the Secretary, the Assistant Secretary for 
Health, and the Director of NIH on mat-
ters relating to arthritis and rheumatic dis-
eases; and 
‘‘(ii) provide advice to the Director of 
the Centers for Disease Control and Pre-
vention, the Commissioner of Food and 
Drugs, and the heads of other relevant 
Federal agencies, on matters relating to 
arthritis and rheumatic diseases. 
‘‘(3) ADMINISTRATIVE SUPPORT; MEETINGS.— 
‘‘(A) 
ADMINISTRATIVE
SUPPORT.—The 
Secretary shall provide necessary and appro-
priate administrative support to the Coordi-
nating Committee. 
‘‘(B) MEETINGS.—The Coordinating Com-
mittee shall meet on a regular basis as deter-
mined by the Secretary, in consultation with the 
Chairperson. 
‘‘(c) ARTHRITIS AND RHEUMATIC DISEASES SUM-
MIT.— 
‘‘(1) IN GENERAL.—Not later than 1 year after 
the date of enactment of the Arthritis Prevention, 
VerDate Aug 31 2005 
17:35 Mar 03, 2007
Jkt 059200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H1283.IH
H1283
pwalker on PROD1PC71 with BILLS
Control, and Cure Act of 2007, the Coordinating 
Committee shall convene a summit of researchers, 
public health professionals, representatives of vol-
untary health agencies, representatives of academic 
institutions, and Federal and State policymakers, to 
provide a detailed overview of current research ac-
tivities at the National Institutes of Health, as well 
as to discuss and solicit input related to potential 
areas of collaboration between the National Insti-
tutes of Health and other Federal health agencies, 
including the Centers for Disease Control and Pre-
vention, the Agency for Healthcare Research and 
Quality, and the Health Resources and Services Ad-
ministration, related to research, prevention, and 
treatment of arthritis and rheumatic diseases. 
‘‘(2) SUMMIT DETAILS.—The summit developed 
under paragraph (1) shall focus on— 
‘‘(A) a broad range of research activities 
relating to biomedical, epidemiological, psycho-
social, and rehabilitative issues, including stud-
ies of the impact of the diseases described in 
paragraph (1) in rural and underserved commu-
nities; 
VerDate Aug 31 2005 
17:35 Mar 03, 2007
Jkt 059200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H1283.IH
H1283
pwalker on PROD1PC71 with BILLS